We are live on ! Find out more
ACM

AIGH Capital Management Portfolio holdings

AUM $1.59B
1-Year Est. Return 855.46%
This Fund
S&P 500
This Quarter Est. Return
-9.54%
1 Year Est. Return
+855.46%
3 Year Est. Return
+3,007.26%
5 Year Est. Return
+4,204.76%
10 Year Est. Return
–
AUM
$211M
AUM Growth
-$33.8M
Cap. Flow
+$8.68M
Cap. Flow %
4.11%
Top 10 Hldgs %
54.93%
Holding
56
New
8
Increased
15
Reduced
11
Closed
8

Top Buys

Rank Stock Value
1
ELVA
Electrovaya
ELVA
+$13.1M
2
ASPN icon
Aspen Aerogels
ASPN
+$12.4M
3
ALIM
Alimera Sciences
ALIM
+$7.84M
4
OUST icon
Ouster
OUST
+$7.13M
5
ASRT
Assertio
ASRT
+$3.68M

Top Sells

Rank Stock Value
1
MCHP icon
Microchip Technology
MCHP
+$22.4M
2
AVNW icon
Aviat Networks
AVNW
+$5.79M
3
ANVS icon
Annovis Bio
ANVS
+$4.58M
4
CMBM
Cambium Networks
CMBM
+$4.52M
5
ANIP icon
ANI Pharmaceuticals
ANIP
+$4.47M

Sector Composition

Rank Sector Weight
1 Healthcare 50.54%
2 Technology 32.16%
3 Industrials 15.26%
4 Consumer Staples 1.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASRT
26
DELISTED
Assertio
ASRT
$2.42M 1.14%
+62,924
New +$3.68M
KPTI icon
27
Karyopharm Therapeutics
KPTI
$45.3M
$2.38M 1.12%
118,232
– –
ELUT icon
28
Elutia
ELUT
$38.3M
$2.3M 1.09%
+1,764,000
New +$3.09M
CVV icon
29
CVD Equipment Corp
CVV
$59.8M
$2.25M 1.06%
335,508
– –
COYA icon
30
Coya Therapeutics
COYA
$110M
$2.06M 0.98%
535,794
-51,078
-9% -$203K
ADVM
31
DELISTED
Adverum Biotechnologies
ADVM
$1.99M 0.94%
132,399
-15,957
-11% -$286K
APLT
32
DELISTED
Applied Therapeutics
APLT
$1.98M 0.94%
+793,350
New +$1.31M
CLRB icon
33
Cellectar Biosciences
CLRB
$20.1M
$1.79M 0.85%
22,584
-4,523
-17% -$266K
THTX
34
DELISTED
Theratechnologies
THTX
$1.73M 0.82%
+803,396
New +$1.72M
APRE icon
35
Aprea Therapeutics
APRE
$8.14M
$1.46M 0.69%
349,300
– –
CGRN
36
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$1.28M 0.6%
1,800,000
+1,196,247
+198% +$988K
MDNA
37
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$1.27M 0.6%
4,339,983
– –
FKWL icon
38
Franklin Wireless
FKWL
$27M
$1.25M 0.59%
390,000
– –
VCNX
39
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$1.23M 0.58%
77,870
+71,429
+1,109% +$3.63M
CAMP
40
DELISTED
CalAmp Corp.
CAMP
$1.22M 0.58%
131,180
+41,895
+47% +$702K
TFFP
41
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$929K 0.44%
106,209
+43,988
+71% +$412K
DFSC
42
DEFSEC Technologies
DFSC
$3.44M
$899K 0.43%
2,648
+761
+40% +$322K
IPWR icon
43
Ideal Power
IPWR
$77.2M
$894K 0.42%
91,947
-64,414
-41% -$713K
ANVS icon
44
Annovis Bio
ANVS
$78.7M
$464K 0.22%
48,941
-370,129
-88% -$4.58M
OSA
45
DELISTED
ProSomnus, Inc. Common Stock
OSA
$399K 0.19%
378,528
-7,905
-2% -$11.9K
TPST icon
46
Tempest Therapeutics
TPST
$14.7M
$125K 0.06%
31,250
– –
DFSCW
47
CALL
DEFSEC Technologies Warrant
DFSCW
$124K 0.06%
599,000
– –
SVREW
48
CALL
SaverOne 2014 Ltd Warrant
SVREW
$79.2K 0.04%
568,694
– –
APPS icon
49
Digital Turbine
APPS
$1.71B
– –
-171,680
Closed -$1.59M
BCLI
50
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
– –
-47,216
Closed -$1.46M
1
2
3

Similar funds

VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

AIGH Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, AIGH Capital Management held 56 positions worth $211M, down 14% from $245M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

AIGH Capital Management deployed $8.68M of net new capital in Q3 2023, opening 8 new positions and adding to 15 existing holdings. Its largest new stake was Electrovaya: 3,353,308 shares worth $9.58M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 45% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Aviat Networks, an estimated $5.79M trimmed.

  • AIGH Capital Management's largest Q3 2023 buy was Electrovaya: 3,353,308 shares worth $9.58M.
  • AIGH Capital Management added most to Vaccinex, Inc. Common Stock in Q3 2023, an estimated $3.63M increase.
  • AIGH Capital Management's biggest Q3 2023 reduction was Aviat Networks, cutting an estimated $5.79M.
  • AIGH Capital Management fully exited Microchip Technology in Q3 2023, selling an estimated $22.4M.
  • AIGH Capital Management's ten largest holdings make up 55% of its $211M portfolio in Q3 2023.
  • AIGH Capital Management opened 8 new positions and closed 8 in Q3 2023.
  • AIGH Capital Management's portfolio value fell 14% quarter-over-quarter to $211M.

Based on AIGH Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.